Efficacy and Safety of Oral Nalbuphine Extended Release in Prurigo Nodularis: Results of a Phase 2 Randomized Controlled Trial with an Open‐Label Extension Phase
2021 ◽
Vol 85
(3)
◽
pp. AB72
2016 ◽
Vol 75
(Suppl 2)
◽
pp. 597.2-598
2017 ◽
Vol 19
(5)
◽
pp. 654-663
◽
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 863.2-864
◽